Head of Global Market Access and Pricing Policy
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Søborg
Are you an experienced Market Access leader with a strong interest and ability to navigate the complex and dynamic external Health Technology Assessment (HTA) and Pricing environment? Do you want to shape how Novo Nordisk can respond strategically and policy wise? Then you might be the right fit to become our new Head of Global Market Access and Pricing Policy, read more an apply now! The position The pricing and market access policy landscape is changing rapidly and in nearly every market around the world. Novo Nordisk is seeking a seasoned market access leader to ensure we are able to understand and respond to our changing environment. As our new Head of Global Market Access and Pricing Policy, you will partner with colleagues from across the organisation to develop and execute awareness and shaping activities with particular attention to ensuring that the full range of market access technical capabilities are appropriately represented. Your primary responsibilities will include:
• Develop pricing and market access policy shaping priorities to proactively engage and influence
• Identify required market access capabilities to navigate the complex pricing/access policy environment
• Develop and maintain strong relationships with stakeholders
• Ensure policy considerations are reflected in all access strategies
• Share best practices In addition, you will lead development and articulation of company positions on pricing and access policy related topics in collaboration with Public Affairs. Qualifications To succeed in the role, you:
• Have 5 years minimum of experience within market access and public affairs
• Ideally have experience from both strategic and operational market access roles
• Ideally have experience within the global, regional and country setting of a company
• Have strong commercial understanding
• Are proficient in English As a person, you show a high degree of proactivity, ambition, personal drive and have an innovative and creative mindset. Also, you are comfortable driving change management and you engage stakeholders using your excellent communication skills. Finally, you bring a good sense of humour to work and thrive in a changing and dynamic environment. About the department Global Evidence, Pricing & Access (GEPA) is the global centre of excellence for market access within Novo Nordisk. The area consists of the centres of excellence for Payer Evidence and Strategic Pricing & Contracting and is overall responsible for market access excellence across Novo Nordisk. As such, we ensure that we anticipate future payer requirements and secure optimal access to our products. Working at Novo Nordisk At Novo Nordisk, we don’t wait for change. We drive it. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development, through to manufacturing, marketing, market access and sales – we’re all working to move the needle on patient care. Contact For further information, please contact Tim Lenehan, CVP for Global Evidence, Pricing & Access at +45 3075 0730 Deadline 26 March 2023 You do not need to attach a cover letter to your application, but please include a few sentences about why you are applying in your resume or CV. To ensure an efficient and fair recruitment process, please refrain from adding a photo in your CV.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
• Develop pricing and market access policy shaping priorities to proactively engage and influence
• Identify required market access capabilities to navigate the complex pricing/access policy environment
• Develop and maintain strong relationships with stakeholders
• Ensure policy considerations are reflected in all access strategies
• Share best practices In addition, you will lead development and articulation of company positions on pricing and access policy related topics in collaboration with Public Affairs. Qualifications To succeed in the role, you:
• Have 5 years minimum of experience within market access and public affairs
• Ideally have experience from both strategic and operational market access roles
• Ideally have experience within the global, regional and country setting of a company
• Have strong commercial understanding
• Are proficient in English As a person, you show a high degree of proactivity, ambition, personal drive and have an innovative and creative mindset. Also, you are comfortable driving change management and you engage stakeholders using your excellent communication skills. Finally, you bring a good sense of humour to work and thrive in a changing and dynamic environment. About the department Global Evidence, Pricing & Access (GEPA) is the global centre of excellence for market access within Novo Nordisk. The area consists of the centres of excellence for Payer Evidence and Strategic Pricing & Contracting and is overall responsible for market access excellence across Novo Nordisk. As such, we ensure that we anticipate future payer requirements and secure optimal access to our products. Working at Novo Nordisk At Novo Nordisk, we don’t wait for change. We drive it. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development, through to manufacturing, marketing, market access and sales – we’re all working to move the needle on patient care. Contact For further information, please contact Tim Lenehan, CVP for Global Evidence, Pricing & Access at +45 3075 0730 Deadline 26 March 2023 You do not need to attach a cover letter to your application, but please include a few sentences about why you are applying in your resume or CV. To ensure an efficient and fair recruitment process, please refrain from adding a photo in your CV.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
Information og data
Denne ledige stilling har jobtypen "Marketingmedarbejder", og befinder sig i kategorien "Kommunikation, marketing, salg".
Arbejdsstedet er beliggende i Søborg.
Jobbet er oprettet på vores service den 3.3.2023, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Marketingmedarbejder
- Søborg
Lignende jobs
-
DI søger en studerende, der har lyst til at gøre e...
Fri kontaktVil du være med til at lave events, der bliver til gode oplevelser, der engagerer og inspirerer DI’s medlemmer og andre vigtige interessenter, og er du klar på at løbe med bolden på dine egne opgaver? Så har vi en studenterstilling til dig i vores team: Strategiske Events.Få mere info- Marketingmedarbejder
- København V
-
Trade Marketing Representative DK - Open Applicati...
Få mere info- Marketingmedarbejder
- København
-
Global Forecasting Lead/Associate Director
Are you excited by understanding complex commercial market dynamics within CVD, MASH, Alzheimer’s Disease and CKD as well as assessing the impact of strategic decisions and initiatives? Do you have..Få mere info- Marketingmedarbejder
- Søborg
-
Trade Marketing Representative (kørende konsulent)...
BAT Danmark søger Trade Marketing Representative (kørende konsulent) til SjællandDrømmer du om en karriere i en ledende international virksomhed med visionen om at skabe en bedre fremtid - A Be..Få mere info- Marketingmedarbejder
- København
Statistik over udbudte jobs som marketingmedarbejdere i Søborg
Herunder ser du udviklingen i udbudte marketingmedarbejder i Søborg over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal marketingmedarbejdere.
Se flere statistikker her:
Statistik over udbudte marketingmedarbejdere i Søborg over tid
| Dato | Alle jobs som marketingmedarbejdere |
|---|---|
| 22. november 2024 | 6 |
| 21. november 2024 | 5 |
| 20. november 2024 | 6 |
| 19. november 2024 | 5 |
| 18. november 2024 | 5 |
| 17. november 2024 | 5 |
| 16. november 2024 | 5 |
| 15. november 2024 | 5 |
| 14. november 2024 | 5 |
| 13. november 2024 | 5 |
| 12. november 2024 | 6 |
| 11. november 2024 | 5 |
| 10. november 2024 | 6 |
| 9. november 2024 | 6 |
| 8. november 2024 | 5 |
| 7. november 2024 | 4 |
| 6. november 2024 | 4 |
| 5. november 2024 | 3 |
| 4. november 2024 | 2 |
| 3. november 2024 | 2 |
| 2. november 2024 | 2 |
| 1. november 2024 | 2 |
| 31. oktober 2024 | 2 |
| 30. oktober 2024 | 2 |
| 29. oktober 2024 | 2 |
| 28. oktober 2024 | 3 |
| 27. oktober 2024 | 4 |
| 26. oktober 2024 | 3 |
| 25. oktober 2024 | 3 |
| 24. oktober 2024 | 4 |
| 23. oktober 2024 | 3 |